source
- AbCellera, Silence and InduPro secure major funding rounds as AbCellera completes $200M share saleVancouver based biotech AbCellera announced a $200 million share offering after meeting its efficacy targets in a Phase 2 hot flashes trial. The capital raise follows the company achieving its pred…
- Definium's LSD pill shows significant anxiety reduction in Phase 3 trialDefinium Therapeutics announced results of a Phase 3 trial testing its LSD‑based pill DT120 in patients with generalized anxiety disorder. The study enrolled 214 participants who received a single…